Related Experiment Video
Updated: May 11, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Atrial fibrillation-induced cardiac troponin I release
Abdul Shokor Parwani1, Leif-Hendrik Boldt, Martin Huemer
1Department of Cardiology, Charité, Campus Virchow Clinic, Berlin, Germany.
Insights
Elevated cardiac troponin I (cTnI) levels are common in patients with atrial fibrillation (AF) and may not indicate myocardial infarction. High heart rate and angina can cause false elevations, necessitating revised clinical guidelines.
Area of Science:
- Cardiology
- Biomarkers
- Emergency Medicine
Background:
- Cardiac troponin I (cTnI) is a key biomarker for diagnosing myocardial damage and acute coronary syndrome.
- Atrial fibrillation (AF) is a common arrhythmia that can present with symptoms overlapping those of acute coronary syndrome.
- The utility and predictive value of cTnI in AF patients presenting with acute symptoms remain to be fully elucidated.
Purpose of the Study:
- To investigate the utility and predictive value of cardiac troponin I (cTnI) in patients diagnosed with atrial fibrillation (AF) presenting with symptoms suggestive of myocardial ischemia.
- To determine the association between elevated cTnI levels and coronary artery disease in this patient population.
Main Methods:
- A cohort of 354 consecutive patients with a primary diagnosis of AF and ischemic symptoms were studied.
- Cardiac troponin I (cTnI) was measured on presentation; patients with ST-segment elevation myocardial infarction were excluded.
- Coronary angiography was performed in 100 patients to assess for significant coronary stenosis.
Main Results:
- Fifteen percent (51/354) of AF patients exhibited elevated cTnI levels (>0.09 μg/L).
- Among patients undergoing coronary angiography, elevated cTnI had a low positive predictive value (26%) for significant stenosis, while normal cTnI had a 33% rate of significant stenosis.
- Multivariate analysis identified heart rate, angina, left ventricular ejection fraction, serum creatinine, and hemoglobin as independent predictors of elevated cTnI.
Conclusions:
- Atrial fibrillation in the acute setting is frequently associated with elevated cTnI levels, often unrelated to significant coronary artery disease.
- Factors such as high heart rate and angina pectoris can lead to false-positive cTnI elevations in AF patients.
- Clinical guidelines for interpreting cTnI in patients with acute AF and ischemic symptoms require revision to account for AF-related elevations.
Background:
Cardiac troponin I (cTnI) is highly specific for myocardial damage and for the diagnosis of acute coronary syndrome. We investigated cTnI utility and predictive value in patients with atrial fibrillation (AF) in the acute setting.
Method:
We studied 354 consecutive patients with the primary diagnosis of AF and clinical symptoms suggestive of myocardial ischemia presenting to our emergency department. cTnI was obtained on presentation. Patients with ST-segment elevation myocardial infarction were excluded. Coronary angiography was performed in 100 patients.
Results:
cTnI was elevated (>0.09 μg/L) in 51 of 354 (15%) patients. The mean cTnI in these patients was 0.37 μg/L (0.09-3.14). In 23 of 100 patients undergoing coronary angiography, cTnI was elevated. Only 6 of these 23 patients (26%) had significant stenosis. In 77 of 100 patients undergoing coronary angiography, cTnI was normal, revealing significant stenosis in 25 patients (33%). The positive predictive value of elevated cTnI for a coronary intervention was 26% and the negative predictive value was 68%. Using multivariate logistic regression, we found that heart rate on presentation, the presence of angina pectoris, left ventricular ejection fraction, serum creatinine, and hemoglobin independently predicted elevated cTnI level.
Conclusion:
These data are the first to show that AF in the acute setting is frequently associated with cTnI elevations. AF patients with high heart rate and/or angina pectoris often show false elevated cTnI levels. These findings are relevant for clinicians evaluating patients with acute AF and myocardial ischemia symptoms. Appropriate clinical guidelines must be established that also consider AF-related elevations in cTnI.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
